New hope for Tough-to-Treat myeloma: first human trial of ISB 2001 launches
Disease control
Recruiting now
This early-stage study tests a new drug called ISB 2001 in about 200 people whose multiple myeloma has returned or stopped responding to standard treatments. The main goals are to check the drug's safety and find the right dose. Participants will receive the drug and be closely m…
Phase: PHASE1 • Sponsor: Ichnos Sciences SA • Aim: Disease control
Last updated Apr 26, 2026 19:37 UTC